title: Problems of drug surveillance--an international view.
abstract: The importance of Post Marketing Surveillance (PMS) is stressed, both to determine the therapeutic value of the drug and its adverse effects revealed in a large population of patients. A survey of such adverse effects of anti-epileptic drugs is provided: metabolic, dose-related and idiosyncratic. Problems of monotherapy and of drug interactions are discussed, as well as questions of central nervous system toxicity and of teratogenicity.
authors.affiliation: Medical Department, Fidia S.p.A., Abano Terme (PD), Italy.
authors.forename: M
authors.initials: M
authors.lastname: Massarotti
authors.forename: A M
authors.initials: AM
authors.lastname: Matano
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011358:Product Surveillance, Postmarketing
chemical_list: D000927:Anticonvulsants